DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 040793
The generic ingredient in A-METHAPRED is methylprednisolone sodium succinate. There are forty drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the methylprednisolone sodium succinate profile page.
Summary for 040793
Tradename: | A-METHAPRED |
Applicant: | Hospira Inc |
Ingredient: | methylprednisolone sodium succinate |
Patents: | 0 |
Therapeutic Class: | Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) Inflammatory Bowel Disease Agents |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 40MG BASE/VIAL | ||||
Approval Date: | Nov 25, 2008 | TE: | RLD: | No |
Complete Access Available with Subscription